Community-acquired methicillin-resistant staphylococcus aureus skin and soft tissue infections: Management and prevention

Current Infectious Disease Reports

Volumn 13, Issue 5, 2011, Pages 442-450

  Chen, Luke F ^a   Chastain, Cody ^a   Anderson, Deverick J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CA MRSA; Decolonization; Management; Methicillin resistant Staphylococcus aureus; MRSA, Community acquired; Prevention; Skin and soft tissue infection; Treatment

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFTAROLINE; CEFTAROLINE FOSAMIL; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; HYDROGEN PEROXIDE; LINEZOLID; LONG ACTING DRUG; MINOCYCLINE; RIFAMPICIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TELAVANCIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; CELLULITIS; CLINICAL FEATURE; COMMUNICABLE DISEASE; DISINFECTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPIDEMIC; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION PREVENTION; INFECTION RISK; KIDNEY DYSFUNCTION; LOADING DRUG DOSE; LOEFFLER PNEUMONIA; LOWER RESPIRATORY TRACT INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYOSITIS; NEUROPATHY; NONHUMAN; PATHOGENESIS; PERSONAL HYGIENE; RASH; RHABDOMYOLYSIS; RISK FACTOR; SKIN ABSCESS; SKIN DECONTAMINATION; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS INFECTION; SURGICAL DRAINAGE; TERATOGENICITY; THROMBOCYTOPENIA; TOOTH DISEASE; TREATMENT DURATION; TREATMENT PLANNING; ULTRAVIOLET C RADIATION; UNSPECIFIED SIDE EFFECT;

EID: 80052566626     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0198-4     Document Type: Article

References (50)

1. HF Chambers FR Deleo 2009 Waves of resistance: Staphylococcus aureus in the antibiotic era Nat Rev Microbiol 7 629 641 19680247 10.1038/nrmicro2200 1:CAS:528:DC%2BD1MXpvFCrsLo%3D
2. GJ Moran A Krishnadasan RJ Gorwitz, et al. 2006 Methicillin-resistant S. aureus infections among patients in the emergency department N Engl J Med 355 666 674 16914702 10.1056/NEJMoa055356 1:CAS:528:DC%2BD28Xot12mtLo%3D
3. EE Udo JW Pearman WB Grubb 1993 Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia J Hosp Infect 25 97 108 7903093 10.1016/0195-6701(93)90100-E 1:STN:280:DyaK2c%2FotFaqsw%3D%3D (Pubitemid 23337269)
4. BC Herold LC Immergluck MC Maranan, et al. 1998 Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk JAMA. 279 593 598 9486753 10.1001/jama.279.8.593 1:STN:280:DyaK1c7ks1Wmug%3D%3D (Pubitemid 28110205)
5. RS Daum T Ito K Hiramatsu, et al. 2002 A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds J Infect Dis 186 1344 1347 12402206 10.1086/344326 1:CAS:528:DC%2BD38XovFKjur8%3D (Pubitemid 35193015)
6. RM Klevens MA Morrison SK Fridkin, et al. 2006 Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors Emerg Infect Dis 12 1991 1993 17326962 (Pubitemid 44904946)
7. P Francois S Harbarth A Huyghe, et al. 2008 Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005 Emerg Infect Dis 14 304 307 18258126 10.3201/eid1402.070229 (Pubitemid 351213683)
8. GW Coombs GR Nimmo JC Pearson, et al. 2009 Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006 Commun Dis Intell 33 10 20 19618763
9. WJ Munckhof GR Nimmo J Carney, et al. 2008 Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin- resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study Eur J Clin Microbiol Infect Dis 27 355 364 18278529 10.1007/s10096-007-0449-3 1:CAS:528:DC%2BD1cXlt1Cqsb4%3D
10. K Popovich B Hota T Rice, et al. 2007 Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus J Clin Microbiol 45 2293 2295 17494715 10.1128/JCM.00044-07 (Pubitemid 47203812)
11. BA Diep HF Chambers CJ Graber, et al. 2008 Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men Ann Intern Med 148 249 257 18283202 (Pubitemid 351665484)
12. Centers for Disease Control and Prevention: Diagnosis and Testing of MRSA Infections. Available at: http://www.cdc.gov/mrsa/diagnosis/index.html. Accessed 04/19/2011.
13. U Seybold EV Kourbatova JG Johnson, et al. 2006 Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections Clin Infect Dis 42 647 656 16447110 10.1086/499815 1:CAS:528:DC%2BD28Xit1Slt7Y%3D (Pubitemid 43271378)
14. CL Maree RS Daum S Boyle-Vavra, et al. 2007 Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections Emerg Infect Dis 13 236 242 17479885 10.3201/eid1302.060781 (Pubitemid 46193166)
15. C von Eiff K Becker K Machka, et al. 2001 Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group N Engl J Med 344 11 16 10.1056/NEJM200101043440102 (Pubitemid 32064839)
16. MJ Kuehnert D Kruszon-Moran HA Hill, et al. 2006 Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002 J Infect Dis 193 172 179 16362880 10.1086/499632 1:CAS:528:DC%2BD28XhtVygu74%3D (Pubitemid 43113478)
17. MM Nakamura KL Rohling M Shashaty, et al. 2002 Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population Pediatr Infect Dis J 21 917 922 12394812 10.1097/00006454-200210000-00006 (Pubitemid 35176150)
18. SV Kazakova JC Hageman M Matava, et al. 2005 A clone of methicillin-resistant Staphylococcus aureus among professional football players N Engl J Med 352 468 475 15689585 10.1056/NEJMoa042859 1:CAS:528: DC%2BD2MXptlWktA%3D%3D (Pubitemid 40175973)
19. HA Cook EY Furuya E Larson, et al. 2007 Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus Clin Infect Dis 44 410 413 17205449 10.1086/510681 1:CAS:528:DC%2BD2sXhvFSqtL4%3D (Pubitemid 46151062)
20. R Desai PS Pannaraj J Agopian, et al. 2011 Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites Am J Infect Control 39 219 225 21458684 10.1016/j.ajic.2010.07.005
21. DM Rackham SM Ray AS Franks, et al. 2010 Community-associated methicillin-resistant Staphylococcus aureus nasal carriage in a college student athlete population Clin J Sport Med 20 185 188 20445358 10.1097/JSM. 0b013e3181dba80d
22. GR Golding PN Levett RR McDonald, et al. 2010 A comparison of risk factors associated with community-associated methicillin-resistant and -susceptible Staphylococcus aureus infections in remote communities Epidemiol Infect 138 730 737 20092664 10.1017/S0950268809991488 1:STN:280: DC%2BC3c3it1WjtQ%3D%3D An interesting article that compares and contrasts risk factors of infection by CA-MRSA versus CA-MSSA infections.
23. T Yamamoto A Nishiyama T Takano, et al. 2010 Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance J Infect Chemother 16 225 254 20336341 10.1007/s10156-010-0045-9
24. SK Fridkin JC Hageman M Morrison, et al. 2005 Methicillin-resistant Staphylococcus aureus disease in three communities N Engl J Med 352 1436 1444 15814879 10.1056/NEJMoa043252 1:CAS:528:DC%2BD2MXjtVWltr0%3D (Pubitemid 40471451)
25. JJ Ruhe N Smith RW Bradsher A Menon 2007 Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome Clin Infect Dis 44 777 784 17304447 10.1086/511872 1:CAS:528:DC%2BD2sXjs1Ghu7w%3D (Pubitemid 46365300)
26. LG Miller F Perdreau-Remington AS Bayer, et al. 2007 Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation Clin Infect Dis 44 471 482 17243048 10.1086/511033 1:CAS:528:DC%2BD2sXisVGksr8%3D (Pubitemid 46233247)
27. LG Miller F Perdreau-Remington G Rieg, et al. 2005 Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles N Engl J Med 352 1445 1453 15814880 10.1056/NEJMoa042683 1:CAS:528:DC%2BD2MXjtVWltro%3D (Pubitemid 40471452)
28. DL Swanson RS Vetter 2005 Bites of brown recluse spiders and suspected necrotic arachnidism N Engl J Med 352 700 707 15716564 10.1056/NEJMra041184 1:CAS:528:DC%2BD2MXhtlGhtbk%3D (Pubitemid 40239218)
29. MC Lee AM Rios MF Aten, et al. 2004 Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus Pediatr Infect Dis J 23 123 127 14872177 10.1097/01.inf.0000109288.06912.21 (Pubitemid 38222783)
30. C Liu A Bayer SE Cosgrove, et al. 2011 Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary Clin Infect Dis 52 285 292 21217178 10.1093/cid/cir034 This important article summarizes the current recommendations for treatment of MRSA infections from the Infectious Diseases Society of America (IDSA)
31. K Chua F Laurent G Coombs, et al. 2011 Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy Clin Infect Dis 52 99 114 21148528 10.1093/cid/ciq067 This is a splendid article that describes the evolution of CA-MRSA infections, current molecular epidemiology and implications for therapy.
32. AS Kaka AM Rueda SA Shelburne 3rd, et al. 2006 Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus J Antimicrob Chemother 58 680 683 16840428 10.1093/jac/dkl283 1:CAS:528: DC%2BD28Xotl2lur0%3D (Pubitemid 44288140)
33. LL Han LK McDougal RJ Gorwitz, et al. 2007 High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center J Clin Microbiol 45 1350 1352 17287335 10.1128/JCM.02274-06 1:CAS:528:DC%2BD2sXlt1Oisrw%3D (Pubitemid 46626515)
34. MH Wilcox KJ Tack E Bouza, et al. 2009 Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study Clin Infect Dis 48 203 212 19072714 10.1086/595686 1:CAS:528:DC%2BD1MXit1Gru7k%3D This key article showed non-inferiority of linezolid compared to vancomycin for complicated skin and skin-structure infections. However, the study also found an increased failure rate of linezolid when used for Gram-negative catheter-associated bloodstream infections.
35. CJ Graber MK Wong HA Carleton, et al. 2007 Intermediate vancomycin susceptibility in a community-associated MRSA clone Emerg Infect Dis 13 491 493 17552110 10.3201/eid1303.060960 1:CAS:528:DC%2BD2sXjvVOktrg%3D (Pubitemid 46348141)
36. BA Miller A Gray TW Leblanc, et al. 2010 Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases Clin Infect Dis 50 63 68 10.1086/652656 This article was one of the first descriptions of acute eosinophilic pneumonitis with daptomycin use.
37. RH Drew 2007 Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections Pharmacotherapy 27 227 249 17253914 10.1592/phco.27.2.227 1:CAS:528:DC%2BD2sXitlyjsb8%3D (Pubitemid 46214584)
38. ME Stryjewski DR Graham SE Wilson, et al. 2008 Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms Clin Infect Dis 46 1683 1693 18444791 10.1086/587896 1:CAS:528:DC%2BD1cXnsVOhtLc%3D (Pubitemid 351706765)
39. GR Corey M Wilcox GH Talbot, et al. 2010 Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection Clin Infect Dis 51 641 650 20695801 10.1086/655827 1:CAS:528:DC%2BC3cXht1yhsbbL This article reported the combined analysis of data from two parallel studies of ceftaroline compared with vancomycin and aztreonam for treatment of complicated skin and soft tissue infections (CANVAS I & II).
40. Centers for Disease Control and Prevention: MRSA and the Workplace. Available at: http://www.cdc.gov/niosh/topics/mrsa/. Accessed 4/21/2011.
41. EM Begier K Frenette NL Barrett, et al. 2004 A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns Clin Infect Dis 39 1446 1453 15546080 10.1086/425313 (Pubitemid 39518207)
42. J Rahimian R Khan KA LaScalea 2007 Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections? Infect Control Hosp Epidemiol 28 1415 1416 17952848 10.1086/523273 (Pubitemid 351412096)
43. AE Simor E Phillips A McGeer, et al. 2007 Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization Clin Infect Dis 44 178 185 17173213 10.1086/510392 1:CAS:528:DC%2BD2sXhsVKns7k%3D (Pubitemid 46079977)
44. MW Ellis ME Griffith DP Dooley, et al. 2007 Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial Antimicrob Agents Chemother 51 3591 3598 17682105 10.1128/AAC.01086-06 1:CAS:528:DC%2BD2sXhtFGhtbjO (Pubitemid 47519348)
45. LG Miller BA Diep 2008 Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 46 752 760 18220477 10.1086/526773 1:CAS:528:DC%2BD1cXjslWgtro%3D (Pubitemid 351321562)
46. Nerandzic MM, Cadnum JL, Pultz MJ, Donskey CJ: Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis. 10:197.
47. Rutala WA, Gergen MF, Weber DJ: Room decontamination with UV radiation. Infect Control Hosp Epidemiol. 31:1025-9.
48. JA Otter S Yezli MA Schouten, et al. 2010 Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak Am J Infect Control 38 754 756 20605263 10.1016/j.ajic.2010.03.010
49. JA Otter M Puchowicz D Ryan, et al. 2009 Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital Infect Control Hosp Epidemiol 30 574 577 19415969 10.1086/597544
50. HL Evans TH Dellit J Chan, et al. 2010 Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients Arch Surg 145 240 246 20231624 10.1001/archsurg.2010.5 1:CAS:528:DC%2BC3cXksFGjtbs%3D